Clinical Trials Logo

Borderline Personality Disorder clinical trials

View clinical trials related to Borderline Personality Disorder.

Filter by:

NCT ID: NCT03361826 Completed - Clinical trials for Borderline Personality Disorder

Magnetic Seizure Therapy for the Treatment of Borderline Personality Disorder

Start date: October 17, 2017
Phase: N/A
Study type: Interventional

Suicide is a major public health crisis for which effective new interventions are needed. An innovative new brain stimulation technique called magnetic seizure therapy (MST) shows promise for treating suicidal thinking in chronically depressed individuals. Using a high-risk cohort of suicidal patients with borderline personality disorder (BPD) and treatment resistant major depressive disorder (MDD), this study will evaluate the effectiveness of MST for reducing suicidality and depressive symptoms in an open-label clinical trial of up to 15 treatment sessions. Based on research showing that functioning of the dorsolateral prefrontal cortex (DLPFC) may be disrupted in BPD and place individuals at risk for suicide, the DLPFC will be targeted for stimulation. Moderate-to-highly suicidal patients with BPD beginning dialectical behavioural therapy (DBT) will be recruited using a case-control design, comparing individuals receiving MST and DBT with matched patient control group receiving DBT alone.

NCT ID: NCT03329677 Completed - Clinical trials for Borderline Personality Disorder

An 18-Month Psychotherapy of Borderline Personality Disorder

Start date: January 1, 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to examine the impact of an 18-month psychotherapy treatment for borderline personality disorder. The investigators will examine changes in psychosocial and work functioning in patients with borderline personality disorder using an 18-month psychotherapeutic treatment. The investigators are recruiting female patients between the ages of 18-35 who meet DSM criteria for BPD. The investigators are excluding patients who meet the following criteria: - psychotic disorders - a current major depressive episode - bipolar I disorder - current substance dependence - antisocial personality disorder. - unable to undergo 18-months of twice weekly psychotherapy in NYC (due to the COVID19 pandemic in person meetings are suspended (see detailed description) but will be restated once this is considered safe again) Participants in the study will receive 18-months of twice weekly psychotherapy, free of charge, as well as compensation for follow-up assessments. They may be currently taking psychiatric medication. Participants will be assessed using semi-structured diagnostic interviews, self-report instruments, and computerized tasks in an initial assessment session lasting about 6-8 hours. They will also be assessed using computerized tasks. Follow-up assessments will occur throughout the treatment as well as after the treatment, lasting about 1-4 hours. The investigators will also be collecting information on their treatment history and psychiatric medication as part of the study.

NCT ID: NCT03297840 Recruiting - Clinical trials for Borderline Personality Disorder

Change in Mindfulness in Borderline Personality Disorder

Start date: May 4, 2017
Phase: N/A
Study type: Observational

The current study aims to investigate the effect of dialectical behavioral therapy on mindfulness in patients with Borderline Personality Disorder. A treatment group will be compared to a waitlist control group.

NCT ID: NCT03295838 Completed - Clinical trials for Borderline Personality Disorder

Outcomes of Mentalization-Based Treatment for Borderline Personality Disorder

Start date: February 1, 2007
Phase: N/A
Study type: Interventional

The effects of a psychological treatment, Mentalization-Based Treatment, was studied using a research protocol with patients with mood swings and impulsive behavior (borderline personality disorder).

NCT ID: NCT03209102 Active, not recruiting - Clinical trials for Borderline Personality Disorder

Emotional Regulation and Impulsivity Among Adolescents With Borderline Personality Disorder

ADOLIMIS
Start date: October 4, 2017
Phase: Phase 2
Study type: Interventional

This study aims to better understand the behavioral, neurobiological and hormonal underpinnings of stress and reward reactivity of adolescents suffering from borderline personality disorder compared to healthy adolescents by a multimodal approach based on clinical assessments, structural and functional mri and experimental acute stress exposure.

NCT ID: NCT03191565 Active, not recruiting - Clinical trials for Borderline Personality Disorder

Using Smartphones for Selfmonitoring of Skill-use i Dialectical Behavior Therapy

mDIARY
Start date: June 15, 2017
Phase: N/A
Study type: Interventional

BACKGROUND: Borderline Personality Disorder (BPD) is a serious and debilitating mental disease characterized by difficulties with emotion regulation that leads to unstable and self- destructive behavior and relationships. The prevalence of BPD is between 1% and 5% in the Scandinavian population with similar prevalence rates found in US epidemiologic surveys. BPD increases the risk for suicide by 4-fold, while patients with comorbid BDP and tendency to self-harm have a further 2-fold attenuated risk. BDP is difficult to treat, and even more difficult when co-occurring with other disorders. Dialectical Behavior Therapy (DBT) is the best validated treatment for BPD, showing medium to large effect sizes as compared to treatment as usual for anger, parasuicidality (suicide attempts without an intention to die) and poor mental health. DBT uses self-monitoring as the mainstay of treatment, which helps patients regulate their emotions by means of emotional regulating skills, and reduce problem behavior. Self-monitoring has traditionally been done by means of daily paper diaries. The latest developments in smartphone applications have generated alternatives for ecological momentary assessments of problematic behavior that even prompt patients to practice skills targeting emotion regulation. An example of this is Monsenso's DBT self-monitoring mHealth application (mHealth means mobile health, public health supported by mobile phones). Such applications may enhance treatment success in BPD patients, as they are available to patients at all times. OBJECTIVES: To evaluate the Monsenso's mHealth app with respect to clinical efficacy as an adjunct to DBT-psychotherapy treatment and utility as a way to measure outcomes in BPD patients. METHODS: The study will be a 2-year multi center, randomized controlled trial. In both conditions patients will be followed for one year. Self report data of DBT-skills-use, positive and negative affect, Standardised self report questionnaires on Emotion regulation ability; functioning; borderline symptoms. will be given pre, post and every month. The treatment arm (n=50) will receive the mHealth app that includes coaching suggestions and instructed how to use it. The control arm (n=50) will only use a pen and paper based self-monitoring, as traditionally used in DBT-treatment. STUDY ENDPOINTS: Primary: mean number of days passed per new DBT-Skill learned. Secondary: Borderline personality disorder(BPD)-symptoms, Emotion regulation ability, ratio positive/negative affect.

NCT ID: NCT03180541 Completed - Clinical trials for Personality Disorder, Borderline

Evaluating the Coordinated National Implementation of DBT in Ireland

Start date: December 2013
Phase: N/A
Study type: Interventional

This study aims to evaluate the coordinated implementation of Dialectical Behaviour Therapy in Community Mental Health Services in Ireland. There are three main objectives of the current study: - evaluate the effectiveness of DBT for adults and adolescents attending Community Mental Health Services in multiple sites across Ireland - conduct an economic evaluation of the coordinated implementation of DBT in community settings in Ireland - evaluate the implementation initiative by means of quantity, quality and experience of the coordinated implementation

NCT ID: NCT03166579 Completed - Clinical trials for Personality Disorder, Borderline

Effectiveness Evaluation of 'The Endeavour Programme'

Start date: July 2010
Phase: N/A
Study type: Interventional

This study aims to evaluate the effectiveness of Dialectical Behaviour Therapy for adults with Borderline Personality Disorder attending Community Mental Health Services in Cork, Ireland. The main objective of the current study is to determine if completion of a 12 month DBT programme is associated with improved outcomes in terms of borderline symptoms, anxiety, hopelessness, suicidal behaviour, depression and quality of life. A secondary objective includes assessing client progress across multiple time-points throughout the treatment.

NCT ID: NCT03149926 Not yet recruiting - Clinical trials for Borderline Personality Disorder

Emotional Reaction and Self Injury in Patients With Borderline Personality Disorder and Healthy Controls

Start date: June 2017
Phase: N/A
Study type: Observational

The current study investigates the emotional response of patients with borderline personality disorder and healthy controls on stimuli associated with self-injury.

NCT ID: NCT03139825 Withdrawn - Adolescent Behavior Clinical Trials

Connectivity and Social Cognition in Adolescent Girls With Borderline Personality Disorder, a Pilot Study

EEG-NIRS
Start date: February 22, 2017
Phase: N/A
Study type: Interventional

The disruption of social cognition associated with borderline personality disorder (BPD), and more specifically categorization of facial emotions, remains largely under-studied, despite the high frequency of this pathology in the clinical population. The first results differ from the observations made in adults and this confirms the relevance of studying this theme specifically in adolescence. On the cognitive level, there is a disturbance of the detection and the categorization of the facial emotions in the TPL. The characteristics of this disturbance and its possible association with an attack on the connectivity of the brain remain unknown in adolescence. No functional imaging studies are published in adolescent TPL. This pilot bimodal functional imaging study EEG-NIRS aims to collect preliminary and feasibility data to support a response to upcoming PHRC competitions and eventually offer a science thesis opportunity.